<?xml version="1.0" encoding="UTF-8"?>
<svg height="735.1" width="4165.7" xmlns="http://www.w3.org/2000/svg">
 <g>
  <text svgx:width="0.46,0.45,0.38,0.52,0.38,0.45,0.26,0.45,0.49,0.45,0.32,0.26,0.52,0.55,0.55,0.53,0.38,0.52,0.46,0.52,0.5,0.45,0.53,0.55,0.52,0.45,0.55,0.71,0.45,0.56,0.78,0.55,0.52,0.55,0.55,0.45,0.52,0.38,0.32,0.45,0.55,0.53,0.38,0.45,0.45,0.52,0.55,0.32,0.38,0.45,0.45,0.32,0.45,0.53" y="437.3" x="56.7,61.2,65.6,69.2,74.2,77.9,82.1,84.6,89.0,93.8,98.0,101.2,103.6,108.6,114.0,117.2,122.4,125.9,131.0,135.3,140.3,145.2,149.4,154.6,157.8,162.9,167.3,170.4,177.2,181.5,186.9,194.6,197.7,202.7,208.1,211.3,215.7,220.6,224.3,227.3,231.7,234.9,240.1,243.6,248.0,252.4,257.3,262.7,265.7,269.4,273.7,277.9,281.1,285.3" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">vasorelaxation provoked by AcEO on aorta precontracted</text>
  <text svgx:width="0.7,0.26,0.32,0.54,0.55,0.53,0.54,0.45,0.55,0.45,0.26,0.45,0.53,0.54,0.38,0.26,0.55,0.45,0.55,0.54,0.45,0.38,0.55,0.52,0.45,0.45,0.55,0.55,0.53,0.45,0.38,0.32,0.26,0.45,0.26,0.26,0.45,0.55,0.26,0.55,0.54,0.26,0.52,0.26,0.32,0.45,0.53,0.22,0.55,0.7,0.54,0.45,0.55" y="449.3" x="56.7,63.5,65.9,69.1,74.4,80.2,85.4,90.5,94.9,100.1,104.5,106.9,111.3,116.3,121.6,125.2,127.6,133.0,137.4,143.2,148.5,152.9,156.6,162.4,167.5,171.8,176.2,181.6,187.3,192.5,196.8,200.5,203.4,206.0,210.2,212.7,215.2,219.6,225.4,227.9,233.2,238.5,240.8,245.9,248.3,251.5,255.7,260.9,263.1,268.8,275.7,280.8,285.2" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">with phenylephrine has been partially inhibited, when</text>
  <text svgx:width="0.53,0.38,0.45,0.26,0.55,0.45,0.54,0.52,0.45,0.32,0.45,0.53,0.55,0.7,0.26,0.32,0.54,0.55,0.32,0.54,0.45,0.55,0.83,0.54,0.38,0.45,0.45,0.38,0.26,0.55,0.26,0.45,0.55,0.38,0.45,0.45,0.45,0.53,0.32,0.52,0.38,0.55,0.26,0.55,0.54,0.26,0.52,0.26,0.32,0.52,0.38,0.22,0.55,0.45,0.32,0.38,0.52,0.53,0.26,0.55,0.45" y="461.3" x="56.7,61.6,65.1,69.2,71.5,76.6,80.7,85.7,90.6,94.7,97.6,101.7,106.9,109.2,115.7,118.0,120.9,126.2,128.5,131.4,136.5,140.9,143.1,151.0,156.0,159.5,163.6,167.7,171.1,173.4,178.5,180.8,185.2,187.5,190.9,195.1,199.2,203.3,208.3,211.1,216.0,219.7,221.9,224.2,229.4,234.4,236.7,241.5,243.8,246.7,251.5,254.2,256.3,258.6,262.7,265.6,269.0,273.8,278.8,281.0,286.2" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">preincubated with the muscarinic receptor inhibitor, atropine</text>
  <text svgx:width="0.32,0.5,0.5,0.22,0.5,0.5,0.7,0.58,0.5,0.22,0.5,0.5,0.22" y="473.3" x="56.7,59.6,64.2,68.8,70.7,75.3,79.9,88.5,95.9,100.5,102.4,107.0,111.6" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">(85.69%±6.56;</text>
  <text svgx:width="0.52" y="473.3" x="116.1" style="fill:rgb(19,20,19);font-family:VskgmxAdvTT8861b38f.I;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">p</text>
  <text svgx:width="0.54,0.55,0.5,0.22,0.5,0.5,0.32,0.55,0.32,0.52,0.26,0.48,0.22,0.55,0.5,0.45,0.32,0.22" y="473.3" x="122.9,128.2,129.9,134.5,136.4,141.0,145.6,148.8,151.2,154.1,158.9,161.2,165.6,167.8,170.1,174.7,178.9,181.8" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">&lt; 0.05) (Fig. 5a).</text>
  <text svgx:width="0.57,0.53,0.4,0.54,0.34,0.47,0.24,0.53,0.47,0.53,0.54,0.32,0.55,0.47,0.3,0.3,0.47,0.43,0.32,0.55,0.54,0.3,0.55,0.59,0.43,0.49,0.69,0.55,0.54,0.54,0.55,0.53,0.54,0.34,0.32,0.53,0.55,0.54,0.34,0.47,0.24,0.54,0.43,0.54,0.54,0.53,0.32,0.47,0.54,0.55,0.72,0.24,0.32,0.54" y="497.3" x="56.7,62.0,66.8,70.5,75.5,78.6,82.9,85.1,90.0,94.3,99.3,104.3,107.2,110.0,114.3,117.1,119.9,124.2,128.1,131.1,133.9,138.9,141.6,144.5,149.9,153.8,158.3,164.7,167.4,172.4,177.4,180.2,185.1,190.0,193.2,196.2,201.0,203.9,208.8,212.0,216.3,218.5,223.5,227.4,232.4,237.4,242.3,245.2,249.5,254.5,257.4,264.0,266.2,269.2" style="fill:rgb(19,20,19);font-family:LywycdAdvTT83913201.I;font-size:9.2px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Vasorelaxant effect of AcEO on aorta preincubated with</text>
  <text svgx:width="0.46,0.31,0.64,0.59,0.79,0.49,0.23,0.55,0.64,0.47,0.54,0.34,0.54,0.47,0.47,0.43,0.54,0.54,0.53,0.24,0.53,0.81,0.24,0.54,0.23,0.55,0.69,0.66,0.69,0.55,0.53,0.54,0.54,0.55,0.51,0.31,0.55,0.53,0.31,0.55,0.34,0.31,0.53,0.49,0.5,0.31,0.43,0.64,0.79,0.53" y="509.3" x="56.7,60.9,63.8,69.7,75.2,82.4,86.9,89.1,91.9,97.8,102.1,107.1,110.3,115.2,119.6,123.9,127.8,132.9,137.9,142.8,144.9,149.8,157.3,159.5,164.5,166.6,169.4,175.7,181.8,188.1,190.9,195.8,200.7,205.7,208.5,213.2,216.1,221.2,226.0,228.9,234.0,237.1,240.0,244.9,249.5,254.1,257.0,260.9,266.8,274.1" style="fill:rgb(19,20,19);font-family:LywycdAdvTT83913201.I;font-size:9.2px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">L-NAME, Hydroxycobalamin, ODQ and 8-RP-Br-PET-cGMP</text>
  <text svgx:width="0.76,0.52,0.55,0.38,0.26,0.48,0.55,0.26,0.29,0.26,0.45,0.45,0.55,0.32,0.55,0.53,0.26,0.29,0.29,0.45,0.38,0.45,0.55,0.45,0.45,0.55,0.52,0.55,0.55,0.32,0.54,0.45,0.55,0.46,0.45,0.38,0.52,0.38,0.45,0.26,0.45,0.49,0.45,0.32,0.26,0.52,0.55,0.55,0.45,0.29,0.29,0.45,0.45,0.32,0.55,0.52,0.29" y="521.3" x="56.7,64.1,69.2,73.6,77.4,79.8,84.5,89.7,92.2,95.0,97.4,101.8,106.0,111.4,114.6,118.9,124.1,126.5,129.3,132.1,136.3,140.0,144.3,149.7,153.9,158.3,162.7,167.8,173.2,177.6,180.7,185.8,190.3,194.8,199.2,203.5,207.3,212.3,216.0,220.2,222.7,227.1,231.8,236.2,239.2,241.6,246.7,252.1,256.5,260.9,263.6,266.4,270.8,275.1,278.2,282.7,287.7" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">No significant difference on the vasorelaxation effect of</text>
  <text svgx:width="0.71,0.45,0.56,0.78,0.55,0.32,0.5,0.22,0.5" y="533.3" x="56.7,63.4,67.8,73.2,80.8,85.7,88.9,93.6,95.7" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">AcEO (0.1</text>
  <text svgx:width="0.6" y="533.3" x="100.5" style="fill:rgb(19,20,19);font-family:PcsvrmAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">–</text>
  <text svgx:width="0.5,0.5,0.5" y="533.3" x="106.3,111.2,115.9" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">100</text>
  <text svgx:width="0.54" y="533.3" x="125.7" style="fill:rgb(19,20,19);font-family:YcgjmgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">μ</text>
  <text svgx:width="0.48,0.36,0.83,0.26,0.32,0.55,0.52,0.55,0.55,0.53,0.54,0.45,0.55,0.45,0.26,0.45,0.53,0.54,0.38,0.26,0.55,0.45,0.55,0.53,0.38,0.45,0.45,0.52,0.55,0.32,0.38,0.45,0.45,0.32,0.45,0.53" y="533.3" x="130.9,135.6,139.0,147.2,149.6,152.7,157.6,162.6,168.0,172.9,178.1,183.2,187.6,192.8,197.2,199.6,204.0,209.0,214.3,217.9,220.3,225.7,230.1,234.9,240.1,243.6,248.0,252.4,257.3,262.7,265.7,269.4,273.7,278.0,281.0,285.4" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">g/ml) on phenylephrine precontracted</text>
  <text svgx:width="0.45,0.52,0.38,0.32,0.45,0.55,0.54,0.45,0.46,0.45,0.55,0.52,0.45,0.45,0.55,0.55,0.52,0.52,0.38,0.45,0.38,0.46,0.45,0.53,0.55,0.26,0.55,0.55,0.32,0.54,0.45,0.55,0.53,0.38,0.45,0.38,0.45,0.55,0.45,0.45,0.55,0.52,0.29,0.55,0.76,0.78,0.55,0.38,0.45,0.55,0.32,0.54,0.45,0.38,0.45" y="437.3" x="304.7,309.1,314.1,317.8,320.7,325.1,328.2,333.5,337.6,342.1,346.5,349.5,354.5,358.9,363.1,368.5,371.6,376.6,381.7,385.3,389.7,393.6,398.1,402.3,407.5,410.6,413.0,418.4,421.5,424.7,429.8,434.2,437.3,442.5,446.0,450.3,454.0,458.3,463.7,467.9,472.4,475.4,480.5,483.3,486.3,493.8,501.4,504.5,508.2,512.4,517.9,520.8,526.1,530.5,534.2" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">aorta have been observed in the presence of NO synthase</text>
  <text svgx:width="0.26,0.55,0.54,0.26,0.52,0.26,0.32,0.52,0.38,0.22,0.55,0.56,0.36,0.76,0.71,0.93,0.56,0.55,0.32,0.5,0.5,0.22,0.5,0.5,0.7,0.58,0.55,0.5,0.22,0.5,0.5,0.22" y="449.3" x="304.7,307.3,312.5,317.8,320.2,325.3,327.7,330.8,335.8,339.5,341.6,345.4,350.9,354.3,361.7,368.7,377.8,383.3,387.1,390.3,395.0,399.9,401.8,406.7,411.5,420.2,425.9,427.7,432.6,434.7,439.6,444.3" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">inhibitor; L-NAME (97.27%± 2.82;</text>
  <text svgx:width="0.52" y="449.3" x="450.3" style="fill:rgb(19,20,19);font-family:VskgmxAdvTT8861b38f.I;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">p</text>
  <text svgx:width="0.54,0.55,0.5,0.22,0.5,0.5,0.32,0.22,0.55,0.26,0.55,0.55,0.32,0.54,0.45,0.55,0.53,0.38,0.45,0.38,0.36" y="449.3" x="457.2,462.5,464.4,469.3,471.3,476.2,480.9,484.1,486.2,489.9,492.5,497.9,501.7,504.8,510.0,514.4,518.2,523.4,526.9,531.3,535.1" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">&gt; 0.05), in the pres-</text>
  <text svgx:width="0.45,0.55,0.45,0.45,0.55,0.52,0.29,0.55,0.76,0.78,0.55,0.38,0.45,0.45,0.46,0.45,0.55,0.48,0.45,0.38,0.22,0.55,0.54,0.45,0.53,0.38,0.52,0.49,0.52,0.45,0.52,0.52,0.45,0.26,0.45,0.83,0.26,0.55,0.55,0.32,0.5,0.5,0.22,0.5,0.5,0.7,0.58,0.55,0.5,0.22,0.5,0.5,0.22" y="461.3" x="304.7,309.1,314.4,318.7,323.2,326.7,331.7,334.5,338.1,345.6,353.2,356.7,360.5,364.7,369.0,373.3,377.7,383.0,387.7,391.9,395.6,397.8,401.2,406.5,410.7,415.9,419.5,424.6,429.2,434.2,438.6,443.6,448.7,452.9,455.4,459.7,467.8,470.2,475.6,479.2,482.4,487.1,492.0,494.0,498.9,503.7,512.3,518.0,519.9,524.8,526.8,531.7,536.4" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ence of NO scavenger; hydroxocobalamin (93.99%± 2.32;</text>
  <text svgx:width="0.52" y="473.3" x="304.7" style="fill:rgb(19,20,19);font-family:VskgmxAdvTT8861b38f.I;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">p</text>
  <text svgx:width="0.54,0.55,0.5,0.22,0.5,0.5,0.32,0.22,0.55,0.45,0.55,0.53,0.55,0.26,0.55,0.55,0.32,0.54,0.45,0.55,0.53,0.38,0.45,0.38,0.45,0.55,0.45,0.45,0.55,0.52,0.29,0.55,0.48,0.54,0.45,0.55,0.45,0.26,0.45,0.26,0.55,0.45,0.45,0.45,0.26,0.45,0.38,0.45,0.55,0.26,0.55,0.54,0.26,0.52,0.26,0.32,0.52,0.38,0.22" y="473.3" x="311.7,317.0,318.8,323.7,325.8,330.7,335.4,338.6,340.7,343.3,347.7,353.0,358.2,360.9,363.3,368.7,371.5,374.7,379.8,384.2,386.9,392.1,395.7,400.0,403.7,408.0,413.3,417.7,422.1,424.7,429.8,432.6,435.3,440.0,445.2,449.5,454.8,459.2,461.5,465.9,468.5,471.1,475.5,479.7,484.1,486.5,490.9,494.7,499.1,501.7,504.3,509.6,514.9,517.3,522.3,524.8,527.8,532.9,536.4" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">&gt; 0.05), and in the presence of guanylyl cyclase inhibitor;</text>
  <text svgx:width="0.78,0.73,0.78,0.55,0.32,0.5,0.5,0.22,0.5,0.5,0.7,0.58,0.55,0.5,0.22,0.5,0.5,0.22" y="485.3" x="304.7,312.4,319.4,327.0,331.7,334.9,339.6,344.5,346.5,351.4,356.1,364.8,370.5,372.4,377.3,379.3,384.2,388.9" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ODQ (92.26%± 3.91;</text>
  <text svgx:width="0.52" y="485.3" x="395.7" style="fill:rgb(19,20,19);font-family:VskgmxAdvTT8861b38f.I;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">p</text>
  <text svgx:width="0.54,0.55,0.5,0.22,0.5,0.5,0.32,0.22,0.55,0.77,0.52,0.7,0.45,0.46,0.45,0.38,0.22,0.55,0.38,0.45,0.26,0.45,0.32,0.26,0.46,0.45,0.55,0.26,0.55,0.54,0.26,0.52,0.26,0.36" y="485.3" x="402.7,408.0,409.8,414.7,416.8,421.7,426.4,429.5,431.7,436.3,443.8,448.8,455.6,460.0,464.3,468.7,471.5,473.7,478.3,482.0,486.3,488.7,493.1,496.1,498.6,503.0,507.4,512.0,514.5,519.8,525.1,527.5,532.5,535.1" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">&gt; 0.05). However, relative inhibi-</text>
  <text svgx:width="0.32,0.52,0.38,0.45,0.55,0.45,0.29,0.29,0.45,0.45,0.32,0.55,0.71,0.45,0.56,0.78,0.36,0.26,0.55,0.53,0.54,0.45,0.45,0.53,0.55,0.46,0.45,0.38,0.52,0.38,0.45,0.26,0.45,0.49,0.45,0.32,0.26,0.52,0.55,0.55,0.54,0.45,0.46,0.45,0.55,0.52,0.45,0.45,0.55" y="497.3" x="304.7,307.9,312.8,316.5,320.9,329.2,333.5,336.2,339.1,343.5,347.8,350.9,359.3,366.1,370.4,375.8,383.4,386.9,389.3,394.7,399.8,405.1,409.3,413.7,418.9,427.2,431.6,436.0,439.8,444.8,448.4,452.6,455.2,459.6,464.3,468.6,471.6,474.1,479.2,484.6,492.9,498.2,502.4,506.7,511.1,519.5,524.5,528.9,533.1" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">tory effect AcEO-induced vasorelaxation have been</text>
  <text svgx:width="0.52,0.52,0.38,0.45,0.38,0.46,0.45,0.53,0.55,0.26,0.55,0.55,0.32,0.54,0.45,0.55,0.53,0.38,0.45,0.38,0.45,0.55,0.45,0.45,0.55,0.52,0.29,0.55,0.32,0.54,0.45,0.55,0.45,0.52,0.83,0.53,0.45,0.32,0.26,0.32,0.26,0.46,0.45,0.55,0.45,0.74,0.93,0.56,0.36" y="509.3" x="304.7,309.8,314.8,318.5,322.8,326.7,331.2,335.4,340.6,347.1,349.6,355.0,361.5,364.6,369.8,374.2,380.6,385.8,389.4,393.7,397.4,401.7,407.0,411.4,415.8,422.2,427.2,430.0,436.5,439.7,444.9,449.3,455.9,460.3,465.2,473.3,478.4,482.8,485.8,488.2,491.4,493.8,498.3,502.7,509.2,513.5,520.7,529.8,535.0" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">observed in the presence of the competitive cGMP-</text>
  <text svgx:width="0.53,0.45,0.53,0.45,0.55,0.53,0.45,0.55,0.32,0.55,0.53,0.38,0.52,0.32,0.45,0.26,0.55,0.55,0.5,0.26,0.55,0.45,0.38,0.45,0.55,0.74,0.55,0.32,0.56,0.67,0.74,0.32,0.55,0.26,0.55,0.54,0.26,0.52,0.26,0.32,0.52,0.38,0.22,0.55,0.61,0.53,0.36,0.5,0.36,0.59,0.38,0.36" y="521.3" x="304.7,309.9,314.1,319.3,323.6,329.0,334.0,338.4,343.7,346.8,352.3,357.5,361.0,366.0,369.2,373.4,375.9,381.3,386.8,391.7,394.0,399.4,403.8,407.5,411.9,417.3,424.6,430.0,433.2,438.5,445.0,452.1,455.3,460.7,463.2,468.6,473.8,476.2,481.3,483.7,486.9,491.8,495.5,497.6,503.0,509.0,514.1,517.6,522.5,525.9,531.7,535.0" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">dependent protein kinase G (PKG) inhibitor; Rp-8-Br-</text>
  <text svgx:width="0.56,0.56,0.67,0.36,0.45,0.74,0.93,0.56,0.55,0.32,0.5,0.5,0.22,0.5,0.5,0.7,0.58,0.55,0.5,0.22,0.5,0.5,0.22" y="533.3" x="304.7,310.2,315.6,321.5,325.1,329.3,336.6,345.5,351.0,353.6,356.7,361.5,366.4,368.3,373.2,378.0,386.7,392.4,394.3,399.2,401.2,406.1,410.8" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">PET-cGMP (87.86%± 4.28;</text>
  <text svgx:width="0.52" y="533.3" x="415.5" style="fill:rgb(19,20,19);font-family:VskgmxAdvTT8861b38f.I;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">p</text>
  <text svgx:width="0.54,0.55,0.5,0.22,0.5,0.5,0.32,0.55,0.32,0.52,0.26,0.48,0.22,0.55,0.5,0.52,0.32,0.22" y="533.3" x="422.5,427.8,429.6,434.5,436.5,441.4,446.1,449.3,451.8,455.0,460.0,462.5,467.0,469.2,471.7,476.6,481.6,484.8" style="fill:rgb(19,20,19);font-family:QbgsvgAdvTT86d47313;font-size:9.8px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">&lt; 0.05) (Fig. 5b).</text>
  <text class="image" id="image.6.1" width="467" height="305" y="104.0" x="63.8" style="font-size:8.0px;">image.6.1.64_532.104_409</text>
  <text svgx:width="0.52,0.27,0.58,0.25,0.55,0.55" y="412.2" x="62.7,66.9,69.0,73.7,75.7,78.1" style="fill:rgb(19,20,19);font-family:GyswgcAdvTTaf7f9f4f.B;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Fig. 1</text>
  <text svgx:width="0.61,0.56,0.29,0.77,0.46,0.55,0.44,0.53,0.29,0.53,0.81,0.3,0.53,0.54,0.29,0.45,0.81,0.55,0.53,0.26" y="412.2" x="84.9,89.8,94.3,96.6,102.8,106.4,108.8,112.3,116.5,118.9,123.1,129.6,131.9,136.2,140.5,142.8,146.4,152.9,155.3,159.5" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">GC-MS chromtogram of</text>
  <text svgx:width="0.53,0.18,0.55,0.41,0.5,0.79,0.5,0.42,0.34,0.29,0.28,0.2,0.34" y="412.2" x="164.0,168.3,169.7,172.1,175.2,179.2,185.5,189.5,192.8,195.6,197.9,200.2,201.7" style="fill:rgb(19,20,19);font-family:WqcrxnAdvTT1b53b5fb.I;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">A. campestris</text>
  <text svgx:width="0.45,0.17,0.55,0.48,0.36,0.36,0.48,0.53,0.3,0.21,0.45,0.21,0.55,0.53,0.21,0.21,0.55,0.26,0.58,0.44,0.46,0.67,0.26" y="412.2" x="206.8,210.4,211.8,214.1,218.0,220.9,223.8,227.6,231.9,234.3,235.9,239.5,241.2,243.6,247.8,249.5,251.1,253.5,255.6,260.2,263.7,267.4,272.7" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">L. essential oil (AcEO)</text>
  <text class="image" id="image.6.2" width="283" height="158" y="563.9" x="155.7" style="font-size:8.0px;">image.6.2.156_440.564_722</text>
  <text svgx:width="0.52,0.27,0.58,0.25,0.55,0.55" y="725.1" x="62.7,66.9,69.0,73.7,75.7,78.1" style="fill:rgb(19,20,19);font-family:GyswgcAdvTTaf7f9f4f.B;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Fig. 2</text>
  <text svgx:width="0.56,0.53,0.48,0.81,0.21,0.44,0.45,0.21,0.55,0.36,0.3,0.29,0.52,0.44,0.3,0.52,0.29,0.48,0.36,0.55,0.53,0.26,0.55,0.45,0.53,0.21,0.45,0.3,0.21,0.21,0.48,0.36,0.55,0.44,0.53,0.81,0.54,0.53,0.52,0.53,0.54,0.36,0.55,0.53,0.26" y="725.1" x="84.9,89.4,93.6,97.4,103.9,105.6,109.1,112.7,114.4,116.7,119.6,122.0,124.3,128.5,132.0,134.4,138.6,140.9,144.7,147.6,150.0,154.2,156.3,158.7,162.3,166.5,168.2,171.7,174.2,175.8,177.5,181.3,184.2,186.6,190.1,194.3,200.8,205.1,209.4,213.6,217.8,222.1,225.0,227.3,231.6" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Chemical structures of volatiles compounds of</text>
  <text svgx:width="0.53,0.18,0.55,0.41,0.5,0.79,0.5,0.42,0.34,0.29,0.28,0.2,0.34" y="725.1" x="236.1,240.3,241.8,244.1,247.4,251.4,257.6,261.6,264.9,267.6,270.0,272.2,273.8" style="fill:rgb(19,20,19);font-family:WqcrxnAdvTT1b53b5fb.I;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">A. campestris</text>
  <text svgx:width="0.45,0.17,0.55,0.48,0.36,0.36,0.48,0.53,0.3,0.21,0.45,0.21,0.55,0.53,0.21,0.21,0.55,0.26,0.58,0.44,0.46,0.67,0.26" y="725.1" x="278.9,282.5,283.9,286.2,290.1,293.0,295.9,299.7,304.0,306.4,308.0,311.5,313.2,315.6,319.9,321.5,323.2,325.6,327.7,332.3,335.8,339.5,344.8" style="fill:rgb(19,20,19);font-family:YfhhftAdvTTb5929f4c;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">L. essential oil (AcEO)</text>
  <text svgx:width="0.66,0.23,0.56" y="39.0" x="56.7,61.9,63.8" style="fill:rgb(19,20,19);font-family:NjjblyAdvTTe45e47d2;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Dib</text>
  <text svgx:width="0.45,0.31,0.55,0.52,0.22,0.21,0.55,0.51,0.77,0.55,0.55,0.55,0.52,0.8,0.52,0.22,0.45,0.8,0.45,0.53,0.31,0.52,0.31,0.44,0.55,0.52,0.53,0.52,0.55,0.56,0.22,0.31,0.45,0.31,0.53,0.52,0.31,0.22,0.45,0.45,0.55,0.77,0.45,0.52,0.22,0.42,0.22,0.53,0.45" y="39.0" x="70.6,74.2,76.7,79.1,83.2,85.0,86.7,89.1,93.1,99.3,103.7,106.1,110.5,114.6,121.1,125.2,127.0,130.5,137.0,140.5,144.8,147.2,151.3,153.8,157.4,159.8,163.9,168.2,172.3,174.7,179.2,180.9,183.4,187.0,189.5,193.7,197.9,200.4,202.1,205.7,209.3,211.6,217.8,221.4,225.5,227.3,230.6,232.3,236.6" style="fill:rgb(19,20,19);font-family:GnxlbsAdvTT7329fd89.I;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">et al. BMC Complementary and Alternative Medicine</text>
  <text svgx:width="0.21,0.28,0.51,0.51,0.51,0.51,0.28,0.21,0.51,0.51,0.21,0.51,0.51,0.21" y="39.0" x="242.5,244.2,246.5,250.6,254.7,258.8,262.9,265.2,266.9,271.0,275.1,276.7,280.9,285.0" style="fill:rgb(19,20,19);font-family:MyriadPro-Regular;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> (2017) 17:82 </text>
  <text svgx:width="0.53,0.48,0.55,0.5,0.55,0.51,0.55,0.54,0.29,0.55,0.51,0.51" y="39.0" x="496.1,500.3,504.1,508.6,512.6,514.9,519.0,521.4,525.7,528.1,530.4,534.5" style="fill:rgb(19,20,19);font-family:NjjblyAdvTTe45e47d2;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Page 6 of 15</text>
 </g>
</svg>
